PRM — Proteome Sciences Balance Sheet
0.000.00%
Last trade - 00:00- £8.38m
- £21.78m
- £4.89m
Annual balance sheet for Proteome Sciences, fiscal year end - December 31st, GBP millions except per share, conversion factor applied.
C2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 2.21 | 2.39 | 3.99 | 2.03 | 1.13 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 1.19 | 0.98 | 1.74 | 1.13 | 0.729 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Current Assets | 4.33 | 4.56 | 6.9 | 4.16 | 2.59 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 0.542 | 1.27 | 1.32 | 3.08 | 2.4 |
| Net Goodwill | |||||
| Other Long Term Assets | |||||
| Total Assets | 9.09 | 10 | 12.4 | 11.5 | 9.21 |
| Payable / Accrued | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 11.6 | 11.7 | 12.5 | 12.5 | 14 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 12.5 | 12.8 | 13.3 | 14.5 | 15.7 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Other Equity | |||||
| Total Equity | -3.36 | -2.77 | -0.843 | -3.07 | -6.52 |
| Total Liabilities & Shareholders' Equity | 9.09 | 10 | 12.4 | 11.5 | 9.21 |
| Total Common Shares Outstanding |